The first interim data has been published from a Phase I/II trial testing the safety and tolerability of AMT-130. If…

The role of BTK inhibitors (BTKis) in cancer treatment has been well-established, but what prospects do they have in treating…

Myasthenia gravis (MG) is a rare disorder, exhibiting the archetypic traits of both the neuromuscular junction and autoantibody-mediated disease –…

The 7th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) brought together experts to share the latest…

The European Stroke Organisation (ESO) has published new guidelines for prehospital management of suspected stroke patients, and recommendations, in collaboration…

New treatment strategies are gaining attention in epilepsy, where current therapeutic options are ineffective for many. Learn more about the…

A record-breaking study into the relationship between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS) onset has revealed a 32-fold…

Biomarker research was a major talking point at ECTRIMS 2021. Discover the latest developments discussed at the meeting, from moving…